Abstract
BackgroundAdherence to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) is suboptimal and ranges from 22% to 107%. As non-adherence can result in more disease activity and a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have